Menu Search
Equities

Adcock Ingram Holdings Ltd

AIHLF:PKC

Adcock Ingram Holdings Ltd

Actions
  • Price (USD)2.45
  • Today's Change0.00 / 0.00%
  • Shares traded40.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Aug 16 2023 18:36 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Adcock Ingram Holdings Limited is a South Africa-based healthcare company. The Company is engaged in supplying specialty, branded and generic pharmaceutical products, hospital products, and fast-moving consumer goods (FMCG). Its segments include Consumer, Over the Counter (OTC), Prescription, Hospital, and Other. The Consumer segment is engaged mainly in the FMCG retail space. Its OTC segment focuses on brands sold predominantly in pharmacies. Its Prescription segment markets products prescribed by medical practitioners, and specialized instruments and surgical products. Its Hospital segment supplies hospital and critical care products, including intravenous solutions, blood collection products and renal dialysis systems. Its Other segment includes shared services and other support services, including regulatory services in India, as well as the investment in the Indian joint venture and cash and bank overdraft balances which are managed on a central basis in Southern Africa.

  • Revenue in ZAR (TTM)9.20bn
  • Net income in ZAR874.23m
  • Incorporated2007
  • Employees2.39k
  • Location
    Adcock Ingram Holdings Ltd1 New Road, (c/o New Road & 7th Street),MIDRAND 1682South AfricaZAF
  • Phone+27 116350000
  • Fax+27 865530000
  • Websitehttps://www.adcock.co.za/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.